170 related articles for article (PubMed ID: 9067480)
1. Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice.
Kehrer JP; Margolin SB
Toxicol Lett; 1997 Feb; 90(2-3):125-32. PubMed ID: 9067480
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone attenuates bleomycin-induced changes in pulmonary functions in hamsters.
Schelegle ES; Mansoor JK; Giri S
Proc Soc Exp Biol Med; 1997 Dec; 216(3):392-7. PubMed ID: 9402144
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
5. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
Iyer SN; Margolin SB; Hyde DM; Giri SN
Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
[TBL] [Abstract][Full Text] [Related]
6. Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.
Tian XL; Yao W; Guo ZJ; Gu L; Zhu YJ
Chin Med Sci J; 2006 Sep; 21(3):145-51. PubMed ID: 17086734
[TBL] [Abstract][Full Text] [Related]
7. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
Tanaka KI; Azuma A; Miyazaki Y; Sato K; Mizushima T
Chest; 2012 Oct; 142(4):1011-1019. PubMed ID: 22459774
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
[TBL] [Abstract][Full Text] [Related]
10. Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis.
Rasooli R; Pourgholamhosein F; Kamali Y; Nabipour F; Mandegary A
Inflammation; 2018 Feb; 41(1):134-142. PubMed ID: 28921394
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.
Inomata M; Kamio K; Azuma A; Matsuda K; Kokuho N; Miura Y; Hayashi H; Nei T; Fujita K; Saito Y; Gemma A
Respir Res; 2014 Feb; 15(1):16. PubMed ID: 24507087
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression.
Pourgholamhossein F; Rasooli R; Pournamdari M; Pourgholi L; Samareh-Fekri M; Ghazi-Khansari M; Iranpour M; Poursalehi HR; Heidari MR; Mandegary A
Food Chem Toxicol; 2018 Feb; 112():39-46. PubMed ID: 29273418
[TBL] [Abstract][Full Text] [Related]
13. Effect of pirfenidone on pulmonary fibrosis due to paraquat poisoning in rats.
Seifirad S; Keshavarz A; Taslimi S; Aran S; Abbasi H; Ghaffari A
Clin Toxicol (Phila); 2012 Sep; 50(8):754-8. PubMed ID: 22924653
[TBL] [Abstract][Full Text] [Related]
14. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
Iyer SN; Wild JS; Schiedt MJ; Hyde DM; Margolin SB; Giri SN
J Lab Clin Med; 1995 Jun; 125(6):779-85. PubMed ID: 7539478
[TBL] [Abstract][Full Text] [Related]
15. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
Iyer SN; Gurujeyalakshmi G; Giri SN
J Pharmacol Exp Ther; 1999 Apr; 289(1):211-8. PubMed ID: 10087006
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin and cyclophosphamide toxicity in mice with damaged lung tissue.
Kehrer JP
Toxicology; 1989 Jul; 57(1):69-82. PubMed ID: 2473544
[TBL] [Abstract][Full Text] [Related]
17. Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway.
Liu H; Drew P; Gaugler AC; Cheng Y; Visner GA
Am J Transplant; 2005 Jun; 5(6):1256-63. PubMed ID: 15888029
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and connective tissue changes in cyclophosphamide-induced lung fibrosis in rats.
Venkatesan N; Punithavathi D; Chandrakasan G
Biochem Pharmacol; 1998 Oct; 56(7):895-904. PubMed ID: 9774151
[TBL] [Abstract][Full Text] [Related]
19. Effect of diet-ingested pirfenidone on pulmonary function, cardiovasculature and blood gas measurements in rats.
Mansoor JK; Chen AT; Schelegle ES; Giri S
Res Commun Mol Pathol Pharmacol; 1999 Mar; 103(3):260-8. PubMed ID: 10509737
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis.
Kakugawa T; Mukae H; Hayashi T; Ishii H; Abe K; Fujii T; Oku H; Miyazaki M; Kadota J; Kohno S
Eur Respir J; 2004 Jul; 24(1):57-65. PubMed ID: 15293605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
